Antimicrobial Susceptibility Test-Makers Seek Ways To Shorten FDA Clearance Process

A group of antimicrobial susceptibility test manufacturers are working with US FDA regulators to hasten the clearance process for their products. The agency recent convened a workshop at its Maryland headquarters to help address the issue.

Manufacturers of antimicrobial susceptibility diagnostics want US FDA to revise definitions for strains of microbes used to validate their tests and make other adjustments to how test data is assessed to speed the development process for susceptibility assays.

An industry coalition forwarded such proposals during a Sept

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from In Vitro Diagnostics

More from Diagnostics